Rajaram Narayanan
#532Managing Director and CEO
57
Age
35y
Exp
3y
Tenure
7/10
Risk
🎓 B.E. Engineering · BITS Pilani
📜 MBA · IIFT Delhi
🏛️ BITS
CompensationTBP
Personality
6
Open
7
Cons
5
Extr
6
Agre
4
Neur
Viyash Scientific
Healthcare · Mid Cap
High Growth · Performance-Driven
About
Rajaram Narayanan is the Managing Director and CEO of Viyash Scientific, a Mid Cap company in the Healthcare sector with a market cap of ₹8K Cr. A Transformational leader with 35 years of experience, he is known for data-driven decision-making and aggressive acquirer strategy. Demonstrated high ambition in driving inorganic growth and capacity expansion within the highly competitive API and pharmaceutical manufacturing landscape.
FAQ
What is Rajaram Narayanan's leadership style?
Rajaram Narayanan is classified as a Transformational leader. He is data-driven in decision-making, with a empire expander motivation and startup-speed pace of execution.
What is Rajaram Narayanan's educational background?
Rajaram Narayanan holds a B.E. Engineering from BITS Pilani and a MBA from IIFT Delhi.
Who is the CEO of Viyash Scientific?
Rajaram Narayanan is the Managing Director and CEO of Viyash Scientific. He has been with the company for 3 years and in the current role for 3 years.
Leadership DNA
ArchetypeTransformational
MotivationEmpire Expander
CrisisRestructurer
DecisionData-Driven
GrowthAggressive Acquirer
PeopleNumbers Driven
InnovationFast-Follower
PaceStartup-Speed
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployerDemanding Machine
BrandTechnical-Expert
FocusMarket Expansion
OrientationSector Adjacent
Leadership Evidence
“Demonstrated high ambition in driving inorganic growth and capacity expansion within the highly competitive API and pharmaceutical manufacturing landscape.”
⚡ Crisis●●●●○
As MD of Viyash Scientific, he has focused on consolidating and scaling the specialty pharma portfolio through strategic integration of acquired assets.
🎯 Motivation●●●●○
His leadership at Viyash is characterized by aggressive scaling of manufacturing capacities and market footprint in the API and specialty chemical space.
👥 People●●●●○
Known for a data-driven leadership style, he emphasizes rigorous performance metrics and operational efficiency to drive organizational transformation.
📈 Growth●●●●●
He has led Viyash Scientific's rapid growth strategy, which is fundamentally anchored in the acquisition and integration of pharmaceutical manufacturing units.
💡 Innovation●●●●○
The company focuses on scaling a portfolio of niche and complex generic pharmaceutical products through rapid execution and manufacturing excellence.
🏃 Pace●●●●○
The company has demonstrated an aggressive inorganic growth strategy, rapidly acquiring multiple manufacturing facilities and product dossiers to scale operations.
🌱 Purpose●●●○○
As a private equity-backed pharmaceutical platform, its primary institutional objective is value creation and portfolio expansion in the specialty generics market.
🏷️ Brand●●●●○
The company's market reputation is built upon its specialized manufacturing capabilities and technical expertise in complex therapeutic segments.
🤝 Customer●●●●●
The company operates as a B2B pharmaceutical manufacturer supplying complex generics and APIs to global markets and enterprise-level partners.
💼 Employer●●●○○
The high-growth, acquisition-heavy nature of the business necessitates a performance-driven culture focused on rapid integration and operational efficiency.
📋 Mandate
As a relatively newer player in the pharma space, the firm requires a leader to drive R&D and navigate complex global regulatory landscapes for market entry.
🏢 Culture●●○○○
Focus on high-growth scaling in pharmaceutical generics, led by a professional CEO managing private equity-backed expansion.
Financials
Revenue FY25₹2K Cr
PAT FY25₹22 Cr
Rev CAGR 5Y3.1%
OPM7.7%
NPM1.4%
ROE3.1%
ROCE10.9%
P/E76.5
Fwd P/E20.3
P/B6.1
D/E55.3
Promoter67.9%
Institutional7.3%
Mkt Cap₹8K Cr
Compensation
To Be Published
Data being verified from audited reports
